Menveo (Novartis Vaccines and Diagnostics s.r.l.)
Welcome to the PulseAid listing for the Menveo drug offered from Novartis Vaccines and Diagnostics s.r.l.. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Vaccines and Diagnostics s.r.l. |
| NON-PROPRIETARY NAME: | Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine |
| SUBSTANCE NAME: | |
| TYPE: | VACCINE |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2010-02-19 |
| END MARKETING DATE: | 2018-04-30 |
Menveo VACCINE Details:
| Item Description | Menveo from Novartis Vaccines and Diagnostics s.r.l. |
| LABELER NAME: | Novartis Vaccines and Diagnostics s.r.l. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2010-02-19 |
| END MARKETING DATE: | 2018-04-30 |
| PRODUCT ID: | 46028-208_2f98ff12-1e2c-4eda-b8cb-161a11da65c6 |
| PRODUCT NDC: | 46028-208 |
| APPLICATION NUMBER: | BLA125300 |